1. Home
  2. GSUN vs HEPA Comparison

GSUN vs HEPA Comparison

Compare GSUN & HEPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSUN
  • HEPA
  • Stock Information
  • Founded
  • GSUN 1997
  • HEPA 2013
  • Country
  • GSUN China
  • HEPA United States
  • Employees
  • GSUN N/A
  • HEPA N/A
  • Industry
  • GSUN Other Consumer Services
  • HEPA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSUN Real Estate
  • HEPA Health Care
  • Exchange
  • GSUN Nasdaq
  • HEPA Nasdaq
  • Market Cap
  • GSUN 5.2M
  • HEPA 4.7M
  • IPO Year
  • GSUN 2022
  • HEPA N/A
  • Fundamental
  • Price
  • GSUN $2.81
  • HEPA $0.68
  • Analyst Decision
  • GSUN
  • HEPA Hold
  • Analyst Count
  • GSUN 0
  • HEPA 1
  • Target Price
  • GSUN N/A
  • HEPA N/A
  • AVG Volume (30 Days)
  • GSUN 41.1K
  • HEPA 39.0K
  • Earning Date
  • GSUN 11-26-2024
  • HEPA 11-26-2024
  • Dividend Yield
  • GSUN N/A
  • HEPA N/A
  • EPS Growth
  • GSUN N/A
  • HEPA N/A
  • EPS
  • GSUN N/A
  • HEPA N/A
  • Revenue
  • GSUN $6,336,931.00
  • HEPA N/A
  • Revenue This Year
  • GSUN N/A
  • HEPA N/A
  • Revenue Next Year
  • GSUN N/A
  • HEPA N/A
  • P/E Ratio
  • GSUN N/A
  • HEPA N/A
  • Revenue Growth
  • GSUN N/A
  • HEPA N/A
  • 52 Week Low
  • GSUN $2.21
  • HEPA $0.55
  • 52 Week High
  • GSUN $11.20
  • HEPA $4.47
  • Technical
  • Relative Strength Index (RSI)
  • GSUN 40.37
  • HEPA 52.88
  • Support Level
  • GSUN $2.42
  • HEPA $0.60
  • Resistance Level
  • GSUN $3.27
  • HEPA $0.68
  • Average True Range (ATR)
  • GSUN 0.34
  • HEPA 0.05
  • MACD
  • GSUN 0.12
  • HEPA 0.00
  • Stochastic Oscillator
  • GSUN 32.00
  • HEPA 87.80

About GSUN Golden Sun Education Group Limited

Golden Sun Health Technology Group Ltd is engaged in the provision of education and management services in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistic and consulting services. The company operates in two segments; Education segment and the Wellness segment. Majority of the revenue is generated from the Education segment which offers foreign language tutorial services and other education training management services in China. The wellness segment offers wellness service and related products.

About HEPA Hepion Pharmaceuticals Inc.

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Share on Social Networks: